Fabian Sanchis-Gomar, MD, PhD

Physician-Scientist, Division of Cardiovascular Medicine, Department of Medicine Stanford University Medical Center, Stanford, California

Photograph of Fabian Sanchis-Gomar, MD, PhD.

This year, Fabian Sanchis-Gomar, MD, PhD, was honored with two Mayo Clinic Proceedings highly cited author awards. The award was developed to acknowledge articles for their meaningful contribution to the Journal's Impact Factor.

Dr Sanchis-Gomar and his co-authors were recognized for their articles:

"As of February 2022, these highly cited manuscripts received enough citations to place them in the top 1% of the academic field of Clinical Medicine based on a highly cited threshold for the field and publication year, contributing to Mayo Clinic Proceedings' 2021 Impact Factor," said Karl A. Nath, MB, ChB, Editor-in-Chief of the journal.

"These highly cited articles discuss the roles of obesity and hypertension, including anti-hypertensive drugs, as risk factors for worse prognosis and higher mortality in coronavirus disease 2019 (COVID-19) patients," says Dr Sanchis-Gomar.

Currently, Dr Sanchis-Gomar is a physician-scientist in the Division of Cardiovascular Medicine (Department of Medicine) at Stanford University Medical Center in Stanford, California, under the supervision of Dr Marco V. Perez.

He obtained his BS degree in health sciences with a concentration in physical therapy and then completed a masters at the University of Valencia (Spain). Afterward, he attained his MD and PhD in physiology at the University of Valencia.

Dr Sanchis-Gomar's research investigates the molecular mechanisms of muscle, metabolism, and cardiovascular adaptations to exercise, how exercise can prevent a wide range of diseases, and even how it can be used as therapy. He is further specialized in the effects of exercise on cardiovascular mechanisms, particularly in exercise-induced cardiovascular adaptations and arrhythmias.

He recently published numerous manuscripts regarding Coronavirus Disease 19 (COVID-19) implications in the cardiovascular system. "COVID-19 is associated with cardiac injury, cardiac arrest, arrhythmias, and likely myocarditis," notes Dr Sanchis-Gomar. "Sub-clinical cardiac pathology such as myocarditis, pericarditis, and right ventricular dysfunction in the absence of significant clinical symptoms remains a concern." He adds, "The potential implications of post-COVID-19-related cardiac sequelae and underlying damage in athletic populations are profound, given the concern that exercise during the acute phase of viral myocarditis may exacerbate the myocardial injury and precipitate malignant ventricular arrhythmias."

Dr Sanchis-Gomar has published more than 300 publications in high-impact journals, includingThe New England Journal of Medicine, JACC, Circulation, JAMA, and JAMA Cardiology, and authored 7 book chapters. He serves as a peer-reviewer for more than 50 medical journals, including The Lancet, Circulation, Progress in Cardiovascular Disease, Journal of the American College of Cardiology (JACC), Mayo Clinic Proceedings, and Annals of Internal Medicine , among others. He is an associate editor for the cardiac electrophysiology section of the journal Frontiers in Physiology and Reviews in Cardiovascular Medicine.

View the awards